Detalhe da pesquisa
1.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Cancer Immunol Immunother
; 73(8): 142, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38832989
2.
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.
Cancer Immunol Immunother
; 72(6): 1365-1379, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633661
3.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676282
4.
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.
Int Braz J Urol
; 47(2): 359-373, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284538
5.
Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis.
Crit Rev Oncol Hematol
; 196: 104321, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460929
6.
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.
Clin Genitourin Cancer
; 22(2): 305-314.e3, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38087702
7.
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.
J Cancer Res Clin Oncol
; 150(4): 183, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594593
8.
The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis.
Clin Genitourin Cancer
; 21(3): 324-333, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823017
9.
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study.
Cancers (Basel)
; 14(17)2022 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077679
10.
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
J Cancer Res Clin Oncol
; 146(7): 1829-1845, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410064
11.
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery.
Ther Adv Urol
; 11: 1756287219872324, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31523281
12.
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities
Int. braz. j. urol
; 47(2): 359-373, Mar.-Apr. 2021. tab
Artigo
em Inglês
| LILACS | ID: biblio-1154467